These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28400203)

  • 1. Transcriptomic and genomic features of invasive lobular breast cancer.
    Desmedt C; Zoppoli G; Sotiriou C; Salgado R
    Semin Cancer Biol; 2017 Jun; 44():98-105. PubMed ID: 28400203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma.
    Tasdemir N; Ding K; Savariau L; Levine KM; Du T; Elangovan A; Bossart EA; Lee AV; Davidson NE; Oesterreich S
    Sci Rep; 2020 Jul; 10(1):11487. PubMed ID: 32661241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
    Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
    Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
    Michaut M; Chin SF; Majewski I; Severson TM; Bismeijer T; de Koning L; Peeters JK; Schouten PC; Rueda OM; Bosma AJ; Tarrant F; Fan Y; He B; Xue Z; Mittempergher L; Kluin RJ; Heijmans J; Snel M; Pereira B; Schlicker A; Provenzano E; Ali HR; Gaber A; O'Hurley G; Lehn S; Muris JJ; Wesseling J; Kay E; Sammut SJ; Bardwell HA; Barbet AS; Bard F; Lecerf C; O'Connor DP; Vis DJ; Benes CH; McDermott U; Garnett MJ; Simon IM; Jirström K; Dubois T; Linn SC; Gallagher WM; Wessels LF; Caldas C; Bernards R
    Sci Rep; 2016 Jan; 6():18517. PubMed ID: 26729235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.
    Lee S; Osmanbeyoglu HU
    Breast Cancer Res; 2022 Jul; 24(1):54. PubMed ID: 35906698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
    Ciriello G; Gatza ML; Beck AH; Wilkerson MD; Rhie SK; Pastore A; Zhang H; McLellan M; Yau C; Kandoth C; Bowlby R; Shen H; Hayat S; Fieldhouse R; Lester SC; Tse GM; Factor RE; Collins LC; Allison KH; Chen YY; Jensen K; Johnson NB; Oesterreich S; Mills GB; Cherniack AD; Robertson G; Benz C; Sander C; Laird PW; Hoadley KA; King TA; ; Perou CM
    Cell; 2015 Oct; 163(2):506-19. PubMed ID: 26451490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
    Guiu S; Wolfer A; Jacot W; Fumoleau P; Romieu G; Bonnetain F; Fiche M
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):235-57. PubMed ID: 25129506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma.
    Gruel N; Lucchesi C; Raynal V; Rodrigues MJ; Pierron G; Goudefroye R; Cottu P; Reyal F; Sastre-Garau X; Fourquet A; Delattre O; Vincent-Salomon A
    Eur J Cancer; 2010 Sep; 46(13):2399-407. PubMed ID: 20570624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma.
    Engels CC; Fontein DB; Kuppen PJ; de Kruijf EM; Smit VT; Nortier JW; Liefers GJ; van de Velde CJ; Bastiaannet E
    Br J Cancer; 2014 Jul; 111(3):532-8. PubMed ID: 24937677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
    Andrade VP; Morrogh M; Qin LX; Olvera N; Giri D; Muhsen S; Sakr RA; Schizas M; Ng CK; Arroyo CD; Brogi E; Viale A; Morrow M; Reis-Filho JS; King TA
    Mol Oncol; 2015 Apr; 9(4):772-82. PubMed ID: 25601220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
    Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
    Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
    Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
    Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
    Chen F; Ding K; Priedigkeit N; Elangovan A; Levine KM; Carleton N; Savariau L; Atkinson JM; Oesterreich S; Lee AV
    Cancer Res; 2021 Jan; 81(2):268-281. PubMed ID: 33148662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
    Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
    Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.